- CEO
- Harin Haridas Kanani
- Full Time Employees
- 989
- Sector
- Process industries
- Industry
- Chemicals: specialty
- Address
- Dev Corpora Building Thane MA India 400601
- IPO Date
- May 8, 2019
- Business
- Neogen Chemicals Limited, founded in 1989 and headquartered in Thane, Maharashtra, India, manufactures and exports bromine- and lithium-based specialty chemicals, including a broad range of organic and inorganic compounds such as lithium bromide, lithium chloride, lithium iodide, lithium sulphate, Grignard reagents, bromobenzene, 1,3-dibromopropane, and intermediates derived from bromination, alkylation, acylation, amination, oxidation, dehalogenation, silylation, Halex reaction, Friedel-Crafts, couplings, and chlorination chemistries; it also provides custom synthesis and contract manufacturing services for pharmaceutical, agrochemical, engineering, specialty polymers, photography, construction chemicals, and battery materials sectors. The company operates state-of-the-art manufacturing facilities in Mahape, Navi Mumbai (Maharashtra), Karakhadi, Vadodara (Gujarat), and Dahej SEZ, Bharuch (Gujarat), with exports to 29 countries across Europe, the USA, Middle East, Japan, and other regions. Recent developments include the May 2023 acquisition of BuLi Chemicals India Private Limited (merged effective April 2024), enhancing organolithium derivatives capacity; the incorporation of wholly-owned subsidiary Neogen Ionics Limited in March 2023 for lithium-ion battery electrolytes following a technology acquisition agreement with Japan-based MU Iconic Solutions Corporation; a August 2025 joint venture agreement between Neogen Ionics and Japan's Morita Chemicals Industries (via Morita Investment Limited) to form Neogen Morita New Materials Ltd. for producing solid LiPF6 electrolyte salts with a combined USD 20 million investment; a ₹1,500 crore capital expenditure plan through 2026 focused on battery chemicals, lithium salts, and electrolytes at Dahej expansions; and a July 2025 approval to raise up to ₹200 crore via non-convertible debentures.